They’ve been described as wonder drugs – new medications that can help you lose weight and potentially reduce the risk of heart attacks and strokes. Baillie Gifford investment manager Ross Mathison discusses Novo Nordisk’s Wegovy and other related treatments and the growth opportunity they offer. Capital at risk.
Read more >